Publication: Mobilization of LINE-1 retrotransposons is restricted by Tex19.1 in mouse embryonic stem cells
dc.contributor.author | MacLennan, Marie | |
dc.contributor.author | Garcia-Canadas, Marta | |
dc.contributor.author | Reichmann, Judith | |
dc.contributor.author | Khazina, Elena | |
dc.contributor.author | Wagner, Gabriele | |
dc.contributor.author | Playfoot, Christopher J. | |
dc.contributor.author | Salvador-Palomeque, Carmen | |
dc.contributor.author | Mann, Abigail R. | |
dc.contributor.author | Peressini, Paula | |
dc.contributor.author | Sanchez, Laura | |
dc.contributor.author | Dobie, Karen | |
dc.contributor.author | Read, David | |
dc.contributor.author | Hung, Chao-Chun | |
dc.contributor.author | Eskeland, Ragnhild | |
dc.contributor.author | Meehan, Richard R. | |
dc.contributor.author | Weichenrieder, Oliver | |
dc.contributor.author | Luis Garcia-Perez, Jose | |
dc.contributor.author | Adams, Ian R. | |
dc.contributor.authoraffiliation | [MacLennan, Marie] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Reichmann, Judith] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Playfoot, Christopher J.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Mann, Abigail R.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Dobie, Karen] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Read, David] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Hung, Chao-Chun] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Meehan, Richard R.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Luis Garcia-Perez, Jose] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Adams, Ian R.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland | |
dc.contributor.authoraffiliation | [Garcia-Canadas, Marta] Pfizer Univ Granada Junta Andalucia, PTS Granada, Ctr Genom & Invest Oncol GENYO, Granada, Spain | |
dc.contributor.authoraffiliation | [Salvador-Palomeque, Carmen] Pfizer Univ Granada Junta Andalucia, PTS Granada, Ctr Genom & Invest Oncol GENYO, Granada, Spain | |
dc.contributor.authoraffiliation | [Peressini, Paula] Pfizer Univ Granada Junta Andalucia, PTS Granada, Ctr Genom & Invest Oncol GENYO, Granada, Spain | |
dc.contributor.authoraffiliation | [Sanchez, Laura] Pfizer Univ Granada Junta Andalucia, PTS Granada, Ctr Genom & Invest Oncol GENYO, Granada, Spain | |
dc.contributor.authoraffiliation | [Luis Garcia-Perez, Jose] Pfizer Univ Granada Junta Andalucia, PTS Granada, Ctr Genom & Invest Oncol GENYO, Granada, Spain | |
dc.contributor.authoraffiliation | [Khazina, Elena] Max Planck Inst Dev Biol, Dept Biochem, Tubingen, Germany | |
dc.contributor.authoraffiliation | [Wagner, Gabriele] Max Planck Inst Dev Biol, Dept Biochem, Tubingen, Germany | |
dc.contributor.authoraffiliation | [Weichenrieder, Oliver] Max Planck Inst Dev Biol, Dept Biochem, Tubingen, Germany | |
dc.contributor.authoraffiliation | [Eskeland, Ragnhild] Univ Oslo, Dept Biosci, Oslo, Norway | |
dc.contributor.authoraffiliation | [Eskeland, Ragnhild] Oslo Univ Hosp, Dept Immunol, Norwegian Ctr Stem Cell Res, Oslo, Norway | |
dc.contributor.funder | Medical Research Council | |
dc.contributor.funder | Howard Hughes Medical Institute | |
dc.contributor.funder | Wellcome | |
dc.contributor.funder | Max-Planck-Gesellschaft | |
dc.contributor.funder | Kreftforeningen | |
dc.contributor.funder | Universitetet i Oslo | |
dc.contributor.funder | Ministerio de Economia y Competitividad | |
dc.contributor.funder | H2020 European Research Council ERC | |
dc.contributor.funder | Seventh Framework Programme | |
dc.contributor.funder | Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia | |
dc.contributor.funder | Medical Research Council | |
dc.contributor.funder | MRC | |
dc.date.accessioned | 2023-02-12T02:23:40Z | |
dc.date.available | 2023-02-12T02:23:40Z | |
dc.date.issued | 2017-08-14 | |
dc.description.abstract | Mobilization of retrotransposons to new genomic locations is a significant driver of mammalian genome evolution, but these mutagenic events can also cause genetic disorders. In humans, retrotransposon mobilization is mediated primarily by proteins encoded by LINE-1 (L1) retrotransposons, which mobilize in pluripotent cells early in development. Here we show that TEX19.1, which is induced by developmentally programmed DNA hypomethylation, can directly interact with the L1-encoded protein L1-ORF1p, stimulate its polyubiquitylation and degradation, and restrict L1 mobilization. We also show that TEX19.1 likely acts, at least in part, through promoting the activity of the E3 ubiquitin ligase UBR2 towards L1-ORF1 p. Moreover, loss of Tex19.1 increases L1-ORF1p levels and L1 mobilization in pluripotent mouse embryonic stem cells, implying that Tex19.1 prevents de novo retrotransposition in the pluripotent phase of the germline cycle. These data show that post-translational regulation of L1 retrotransposons plays a key role in maintaining trans-generational genome stability in mammals. | |
dc.identifier.doi | 10.7554/eLife.26152 | |
dc.identifier.issn | 2050-084X | |
dc.identifier.unpaywallURL | https://doi.org/10.7554/elife.26152 | |
dc.identifier.uri | http://hdl.handle.net/10668/19396 | |
dc.identifier.wosID | 407617500001 | |
dc.journal.title | Elife | |
dc.journal.titleabbreviation | Elife | |
dc.language.iso | en | |
dc.organization | Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO | |
dc.publisher | Elife sciences publications ltd | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | High-frequency retrotransposition | |
dc.subject | Human l1 retrotransposition | |
dc.subject | Piwi-interacting rnas | |
dc.subject | End rule pathway | |
dc.subject | Ubiquitin ligase | |
dc.subject | Dna methylation | |
dc.subject | Orf1 protein | |
dc.subject | Transposable elements | |
dc.subject | Chaperone activity | |
dc.subject | Binding protein | |
dc.title | Mobilization of LINE-1 retrotransposons is restricted by Tex19.1 in mouse embryonic stem cells | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 6 | |
dc.wostype | Article | |
dspace.entity.type | Publication |